- Department of Internal Medicine, Military Hospital, Ambala, Haryana, India
- Department of Rheumatology, Command Hospital Southern Command, Pune, Maharashtra, India
- Department of Internal Medicine, Armed Forces Medical College, Pune, Maharashtra, India
Volume 33, Issue 3, September 2022
Sign in to download the Issue in PDF format.
135010288
Mediterr J Rheumatol 2022;33(3):361-7
Article Links
Fever of Unknown Origin and Hepatitis as the Initial Presentation of Anti-MDA-5 Positive Dermatomyositis: A Case Report
References
- L Attard, M Tadolini, D U De Rose, M Cattalini. Overview of fever of unknown origin in adult and paediatric patients. Clin Exp Rheumatol 2018;36 (Suppl. 110):S10-S24.
- Naito T, Tanei M, Ikeda N, Ishii T, Suzuki T, Morita H, et al. Key diagnostic characteristics of fever of unknown origin in Japanese patients: a prospective multicentre study. BMJ Open 2019;9:e032059.
- 3. Rupali P, Garg D, Viggweswarupu S, Sudarsanam T D, Jeyaseelan V, Abraham OC. Etiology of Classic Fever of Unknown Origin (FUO) among Immunocompetent Indian Adults. J Assoc Physicians India 2019;67:21-6.
- Bandyopadhyay D, Bandyopadhyay R, Paul R, Roy D. Etiological study of Fever of unknown origin in patients admitted to medicine ward of a teaching hospital of eastern India. J Glob Infect Dis 2011;3:329-33.
- Cobos GA, Femia A, Vleugels RA. Dermatomyositis: An Update on Diagnosis and Treatment. Am J Clin Dermatol 2020;21:339-53.
- Zhou G, Zhou Y, Zhong C, Ye H, Liu Z, Liu Y, et al. Retrospective analysis of 1,641 cases of classic fever of unknown origin. Ann Transl Med 2020;8:690.
- Lee LW, Narang NS, Postolova A, Seminara N, Kantor MA. Anti-MDA5-Positive Dermatomyositis Presenting as Fever of Unknown Origin. J Gen Intern Med 2016;31:1530-36.
- Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 2005;52:1571-6.
- Fiorentino D, Chung L, Zwerner J, Rosen A, Casciola-Rosen L. The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J Am Acad Dermatol 2011;65:25-34.
- Hamaguchi Y, Kuwana M, Hoshino K, Hasegawa M, Kaji K, Matsushita T, et al. Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study. Arch Dermatol 2011;147:391-8.
- Kurtzman DJB, Vleugels RA. Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis: A concise review with an emphasis on distinctive clinical features. J Am Acad Dermatol 2018;78:776-85.
- Bachmeyer C, Tillie-Leblond I, Lacert A, Cadranel J, Aractingi S. "Mechanic's hands": a misleading cutaneous sign of the antisynthetase syndrome. Br J Dermatol 2007;156:192-4.
- Cao H, Pan M, Kang Y, Xia Q, Li X, Zhao X, et al. Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody. Arthritis Care Res (Hoboken) 2012;64:1602-10.
- Moghadam-Kia S, Oddis CV, Sato S, Kuwana M, Aggarwal R. Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis. J Rheumatol 2017;44:319-25.
- Ceribelli A, Fredi M, Taraborelli M, Cavazzana I, Tincani A, Selmi C, et al. Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis. Clin Exp Rheumatol 2014;32:891-7.
- Koga T, Fujikawa K, Horai Y, Okada A, Kawashiri SY, Iwamoto N, et al. The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM. Rheumatology (Oxford) 2012;51(7):1278-84.
- Takahashi A, Abe K, Yokokawa J, Iwadate H, Kobayashi H, Watanabe H, et al. Clinical features of liver dysfunction in collagen diseases. Hepatol Res 2010;40:1092-7.
- Wada T, Abe G, Kudou T, Ogawa E, Nagai T, Tanaka S, Hirohata S. Liver damage in patients with polymyositis and dermatomyositis. Kitasato Med J 2016;46:40-6.
- Gono T, Kawaguchi Y, Ozeki E, Ota Y, Satoh T, Kuwana M, et al. Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis. Mod Rheumatol 2011;21:223-7.